Guidelines | Treatment | Excellence in Stroke

	Acute Treatment

		AHA Guidelines for the Management of Thrombolytic Therapy: i.v. rt-PA (0.9 mg/kg) with 10% of the dose given as bolus followed by an infusion lasting 60 minutes

		ACC Guidelines for the Management of Thrombolytic Therapy: Preferred therapeutic approach to achieve rapid thrombolysis are plasminogen activators especially rt-PA

		RCP Guidelines for the Management of Thrombolytic Therapy: Aspirin (160-300 mg) should be given as soon as possible after the onset of stroke symptoms if a diagnosis

		Consensus Statement of the 4th Karolinska Stroke Update for Thrombolytic Therapy: i.v. recombinant tissue plasminogen activator (rt-PA) within 3 hours after onset of symptoms in patients

		EUSI Guidelines for the Management of Thrombolytic Therapy: i.v. rt-PA (0.9 mg/kg; max 90 mg, 10 % bolus, followed by 60 min infusion) is recommended within 3 hours

		ACEP Guidelines for for the Management of Acute Stroke in the Emergency Department: The American College of Emergency Physicians (ACEP) endorses the following principles regarding the use of intravenous tPA

		ACCP Guidelines for Acute Ischaemic Stroke Thrombolytic Therapy: AIS Treatment Within 3 h of Symptom Onset

		ACCP Guidelines for Acute Ischaemic Stroke Thrombolytic Therapy: Thrombolytic Therapy – AIS Treatment Within 3 to 6 h of Symptom Onset

		International Guidelines Acute Stroke Recommendations


	Secondary Prevention

		ACCP Guidelines for Stroke Prevention: Non-cardioembolic cerebral ischaemic events

		ACCP Guidelines: Outcome Events in the ESPS 2 Study

		ACCP Guidelines: Outcome Events in the CAPRIE Study:

		International Guidelines Secondary Prevention Recommendations

Imprint | Terms of use


	Search

	Site Map

	Contact